Prosta-omics: machine learning-driven TPSA prediction and molecular modeling of ASPM-inhibitors for prostate cancer treatment
{{output}}
Prostate cancer exhibits complex transcriptional heterogeneity that underlies disease progression and therapeutic resistance. We developed an integrative omics-to-therapy pipeline to identify actionable biomarkers and screen drug candidates using a combination... ...
